Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Acadia Pharmaceuticals (ACAD) Q1 2020 Earnings
ACAD
26
Feb
Confirmed
Q2 2019
Q3 2019
Q4 2019
Q1 2020
-0.59
-0.49
-0.39
-0.29
Details
Expected EPS
-0.35
Actual EPS
-0.34
Surprise EPS
0.01
Surprise Percent
+2.86%
Description
Acadia Pharmaceuticals (ACAD) has reported earnings of -0.34 per share for Q1 2020.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login